Federal Register / Vol. 74, No. 18 / Thursday, January 29, 2009 / Notices 5169 

applicant who has the most of these 

factors, all other criteria being equal, 

will be selected. 

(a) An applicant’s length of current 

employment in the IHS, Tribal, or urban 

program. 

(b) Availability for service earlier than 

other applicants (first come, first 

served). 

(c) Date the individual’s application 

was received. 

3. Anticipated Announcement and 

Award Dates 

Not applicable. 

VI. Award Administration Information 

1. Award Notices 

Notice of awards will be mailed on 

the last working day of each month. 

Once the applicant is approved for 

participation in the LRP, the applicant 

will receive confirmation of his/her loan 

repayment award and the duty site at 

which he/she will serve his/her loan 

repayment obligation. 

2. Administrative and National Policy 

Requirements 

Applicants may sign contractual 

agreements with the Secretary for two 

years. The IHS may repay all, or a 

portion of the applicant’s health 

profession educational loans 

(undergraduate and graduate) for tuition 

expenses and reasonable educational 

and living expenses in amounts up to 

$20,000 per year for each year of 

contracted service. Payments will be 

made annually to the participant for the 

purpose of repaying his/her outstanding 

health profession educational loans. 

Payment of health profession education 

loans will be made to the participant 

within 120 days, from the date the 

contract becomes effective. The effective 

date of the contract is calculated from 

the date it is signed by the Secretary or 

his/her delegate, or the IHS, Tribal, 

urban, or ‘‘Buy-Indian’’ health center 

entry-on duty date, whichever is more 

recent. 

In addition to the loan payment, 

participants are provided tax assistance 

payments in an amount not less than 20 

percent and not more than 39 percent of 

the participant’s total amount of loan 

repayments made for the taxable year 

involved. The loan repayments and the 

tax assistance payments are taxable 

income and will be reported to the 

Internal Revenue Service (IRS). The tax 

assistance payment will be paid to the 

IRS directly on the participant’s behalf. 

LRP award recipients should be aware 

that the IRS may place them in a higher 

tax bracket than they would otherwise 

have been prior to their award. 

3. Contract Extensions 

Any individual who enters this 

program and satisfactorily completes his 

or her obligated period of service may 

apply to extend his/her contract on a 

year-by-year basis, as determined by the 

IHS. Participants extending their 

contracts may receive up to the 

maximum amount of $20,000 per year 

plus an additional 20 percent for 

Federal withholding. 

VII. Agency Contacts 

Please address inquiries to Ms. 

Jacqueline K. Santiago, Chief, IHS Loan 

Repayment Program, 801 Thompson 

Avenue, Suite 120, Rockville, Maryland 

20852, PH: 301/443–3396 [between 8 

a.m. and 5 p.m. (EST) Monday through 

Friday, except Federal holidays]. 

VIII. Other Information 

IHS Area Offices and Service Units 

that are financially able are authorized 

to provide additional funding to make 

awards to applicants in the LRP, but not 

to exceed $35,000 a year plus tax 

assistance. All additional funding must 

be made in accordance with the priority 

system outlined below. Health 

professions given priority for selection 

above the $20,000 threshold are those 

identified as meeting the criteria in 25 

U.S.C. 1616a(g)(2)(A) which provides 

that the Secretary shall consider the 

extent to which each such 

determination 

(i) Affects the ability of the Secretary 

to maximize the number of contracts 

that can be provided under the LRP 

from the amounts appropriated for such 

contracts; 

(ii) Provides an incentive to serve in 

Indian health programs with the greatest 

shortages of health professionals; and 

(iii) Provides an incentive with 

respect to the health professional 

involved remaining in an Indian health 

program with such a health professional 

shortage, and continuing to provide 

primary health services, after the 

completion of the period of obligated 

service under the LRP. 

Contracts may be awarded to those 

who are available for service no later 

than September 30, 2009, and must be 

in compliance with any limits in the 

appropriation and Section 108 of the 

IHCIA not to exceed the amount 

authorized in the IHS appropriation (up 

to $32,000,000 for FY 2009). In order to 

ensure compliance with the statutes, 

Area Offices or Service Units providing 

additional funding under this section 

are responsible for notifying the LRP of 

such payments before funding is offered 

to the LRP participant. 

Should an IHS Area Office contribute 

to the LRP, those funds will be used for 

only those sites located in that Area. 

Those sites will retain their relative 

ranking from the national site-ranking 

list. For example, the Albuquerque Area 

Office identifies supplemental monies 

for dentists. Only the dental positions 

within the Albuquerque Area will be 

funded with the supplemental monies 

consistent with the national ranking and 

site index within that Area. 

Should an IHS Service Unit 

contribute to the LRP, those funds will 

be used for only those sites located in 

that Service Unit. Those sites will retain 

their relative ranking from the national 

site-ranking list. For example, Chinle 

Service Unit 15 identifies supplemental 

monies for pharmacists. The Chinle 

Service Unit consists of two facilities, 

namely the Chinle Comprehensive 

Health Care Facility and the Tsaile PHS 

Indian Health Center. The national 

ranking will be used for the Chinle 

Comprehensive Health Care Facility 

(Score = 44) and the Tsaile PHS Indian 

Health Center (Score = 46). With a score 

of 46, the Tsaile PHS Indian Health 

Center would receive priority over the 

Chinle Comprehensive Health Care 

Facility. 

Dated: January 21, 2009. 

Robert G. McSwain, 

Director, Indian Health Service. 

[FR Doc. E9–1793 Filed 1–28–09; 8:45 am] 

BILLING CODE 4165–16–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Arthritis and 

Musculoskeletal and Skin Diseases Special 

Grants Review Committee. 

Date: February 17–18, 2009. 

Time: 7 p.m. to 5 p.m. 


rmajette on PRODPC74 with NOTICES
5170 Federal Register / Vol. 74, No. 18 / Thursday, January 29, 2009 / Notices 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites Hotel at the Chevy 

Chase Pavilion, Chevy Chase Pavilion, 4300 

Military Rd, NW., Washington, DC 20015. 

Contact Person: Helen Lin, PhD, Scientific 

Review Administrator, NIH/NIAMS/RB, 6701 

Democracy Blvd., Suite 800, Plaza One, 

Bethesda, MD 20817, 301–594–4952, 

linh1@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.846, Arthritis, 

Musculoskeletal and Skin Diseases Research, 

National Institutes of Health, HHS) 

Dated: January 23, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–1959 Filed 1–28–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Oligosaccharides 

Autimicrobial and Prebiotic—RFA. 

Date: February 26, 2009. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Peter Zelazowski, PhD, 

Scientific Review Officer, Division of 

Scientific Review, Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development, NIH, 6100 Executive 

Boulevard, Rm. 5B01, Bethesda, MD 20892– 

7510, 301–435–6902, 

peter.zelazowski@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: January 23, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–1967 Filed 1–28–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Cancer 

Advisory Board Ad Hoc Subcommittee 

on Communications, February 2, 2009, 

6:30 p.m. to 8 p.m., Bethesda Marriott 

Suites, 6711 Democracy Boulevard, 

Bethesda, MD 20814 and the meeting of 

the National Cancer Advisory Board, 

February 3–4, 2009, 8 a.m. to 12 p.m., 

National Institutes of Health, Building 

31, 31 Center Drive, Bethesda, MD 

20892, which was published in the 

Federal Register on January 21, 2009 74 

FR 3622. 

This notice is amended to cancel the 

meeting of the National Cancer 

Advisory Board Ad Hoc Subcommittee 

on Communications and to change the 

end time of the National Cancer 

Advisory Board closed session on 

February 3 to 5:15 p.m. The closed 

session will be held from 4 p.m. to 5:15 

p.m. Also, to change the start time of the 

open session of the National Cancer 

Advisory Board meeting on February 4 

to 8:30 a.m. 

Dated: January 22, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–1863 Filed 1–28–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Innovative 

Methods Manufacturing Cancer 

Therapeutics. 

Date: February 26, 2009. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Conference Room 406, 

Rockville, MD 20852 Telephone Conference 

Call). 

Contact Person: Joyce C. Pegues, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Boulevard, Room 7149, 

Bethesda, MD 20892–8329, 301–594–1286, 

peguesj@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Innovations in Cancer Sample Preparation. 

Date: March 11–12, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6116 

Executive Blvd., Room 8053, Rockville, MD 

20852 (Virtual Meeting). 

Contact Person: Sherwood Githens, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Blvd., Room 8053, Bethesda, 

MD 20892, 301/435–1822, 

githenss@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Anticancer 

Agents. 

Date: March 12–13, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Thomas M. Vollberg, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activites, National Cancer Institute, NIH, 

6116 Executive Boulevard, Room 7142, 

Bethesda, MD 20892, 301–594–9582, 

vollbert@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Novel 

Antibody Epitope Mapping Technologies. 

Date: March 17, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Rockville, MD 20852 

(Telephone Conference Call). 


rmajette on PRODPC74 with NOTICES